Vaccines to treat cancer possible by 2030, say BioNTech founders

Uur ahin and Ozlem Tureci say mRNA Covid vaccine technology could be repurposed to help destroy cancer cells

Vaccines that target cancer could be available before the end of the decade, according to the husband and wife team behind one of the most successful Covid vaccines of the pandemic.

Uur ahin and Ozlem Tureci, who co-founded BioNTech, the German firm that partnered with Pfizer to manufacture a revolutionary mRNA Covid vaccine, said they had made breakthroughs that fuelled their optimism for cancer vaccines in the coming years.